生物活性 | |||
---|---|---|---|
靶点 |
|
||
描述 | HDAC3, the most highly expressed class I HDAC in the brain, is a key negative regulator of gene expression required for long-term memory formation. RGFP966 is specific inhibitor of HDAC3 with an IC50 of 0.08 μM and no effective inhibition of any other HDAC at concentrations up to 15 μM (measured by enzymatic activity of recombinant human HDACs). A series of function in memory of RGFP966 has been done. 10 mg/kg RGFP966 subcutaneously posttreatment cause increased H4K8Ac, a site regulated by HDAC3 activity in the brain, and H3K14Ac, correlating with learning, in infralimbic cortex of mice at 1 h after the first extinction session of cocaine-CPP[1]. A posttraining injection of RGPF966 (10 mg/kg, s.c.) following the daily training session in rat can alter the formation of auditory memory by enabling more acoustic information to become encoded into memory and affect the cortical plasticity[2]. A study shows the function of RGFP966 in lymphoid and myeloid malignancies. Incubation with RGFP966 (<1uM,48h) significantly slowed down the proliferation of Eu-Myc lymphoma cells and increased maturation of APL cells, without induction of apoptosis[3]. | ||
作用机制 | The ortho-aminoanilide structure of RGFP966 is the zinc-binding moiety.[4] |
细胞研究 | |||||
---|---|---|---|---|---|
细胞系 | 浓度 | 检测类型 | 检测时间 | 活动说明 | 数据源 |
APL cells | ≤2 μM | Function assay | 48 h | RGFP966 did not induce apoptosis in APL cells but did reduce clonogenicity and increased maturation. | 26447190 |
Em-Myc lymphoma cells | ≤1 μM | Function assay | 48 h | Cell proliferated significantly more slowly than vehicle-treated controls in the presence or absence of pro-survival BCL-2 overexpression | 26447190 |
HH | 10 μM | Function assay | 24 h | increases the acetylation at H3K9/K14, H3K27, and H4K5 | 23894374 |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.76mL 0.55mL 0.28mL |
13.80mL 2.76mL 1.38mL |
27.59mL 5.52mL 2.76mL |
参考文献 |
---|